Published in Pharmacol Ther on February 19, 2010
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol (2011) 2.90
The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol (2014) 2.13
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 1.40
Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol (2012) 1.28
Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev (2011) 1.24
Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol (2013) 1.16
Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest (2014) 1.15
Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig (2013) 1.13
Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05
The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr (2015) 1.00
Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol (2011) 0.99
Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol (2014) 0.97
Autonomic nervous system in the control of energy balance and body weight: personal contributions. Neurol Res Int (2013) 0.97
Effects of Chronic Social Stress on Obesity. Curr Obes Rep (2012) 0.96
Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity. Front Physiol (2012) 0.95
Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. Int J Mol Sci (2013) 0.95
Orexin-A controls sympathetic activity and eating behavior. Front Psychol (2014) 0.95
Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome. J Am Heart Assoc (2013) 0.94
Arcuate nucleus - a gateway for insulin's action on sympathetic activity. J Physiol (2011) 0.93
Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One (2013) 0.93
Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats. Diabetologia (2015) 0.92
Insulin resistance: a new consequence of altered carotid body chemoreflex? J Physiol (2016) 0.91
Creb coactivators direct anabolic responses and enhance performance of skeletal muscle. EMBO J (2014) 0.91
Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension. Front Physiol (2012) 0.91
Autonomic cardiac innervation: development and adult plasticity. Organogenesis (2013) 0.91
Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation. J Physiol (2014) 0.91
Cardiac autonomic functions in obese children. J Clin Res Pediatr Endocrinol (2011) 0.90
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects. J Am Heart Assoc (2012) 0.90
A sympathetic view of human obesity. Clin Auton Res (2012) 0.90
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome. J Diabetes Res (2015) 0.89
Obesity-induced increases in sympathetic nerve activity: sex matters. Auton Neurosci (2014) 0.87
Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. J Neurosci (2011) 0.87
Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature. J Physiol (2011) 0.85
Parasympathetic cardiac activity is associated with cardiorespiratory fitness in overweight and obese adolescents. Pediatr Cardiol (2013) 0.85
Interaction of the endocrine system with inflammation: a function of energy and volume regulation. Arthritis Res Ther (2014) 0.85
Carotid body, insulin, and metabolic diseases: unraveling the links. Front Physiol (2014) 0.84
Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo. Cardiovasc Diabetol (2014) 0.84
Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2. Sci Signal (2015) 0.83
Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome? Front Endocrinol (Lausanne) (2012) 0.83
Relationships of adrenoceptor polymorphisms with obesity. J Obes (2011) 0.82
Relationship of adiposity and cardiorespiratory fitness with resting blood pressure of South African adolescents: the PAHL Study. J Hum Hypertens (2015) 0.82
Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transBATation). Physiol Behav (2013) 0.81
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats. Diabetes (2014) 0.81
Importance of adrenergic pathways in women's cancers. Cancer Biomark (2013) 0.80
Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health (2015) 0.80
Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology. Adv Nutr (2014) 0.80
Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias. Am J Physiol Heart Circ Physiol (2013) 0.80
Associations between socioeconomic status and catecholamine levels vary by acculturation status in Mexican-American women. Ann Behav Med (2012) 0.79
Association of blood glucose level and hypertension in Elderly Chinese Subjects: a community based study. BMC Endocr Disord (2016) 0.78
Relationship of muscle sympathetic nerve activity to insulin sensitivity. Clin Auton Res (2014) 0.78
Does bariatric surgery improve adipose tissue function? Obes Rev (2016) 0.78
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus. J Diabetes Res (2015) 0.78
Cardiovascular Regulation in Obstructive Sleep Apnea. Drug Discov Today Dis Models (2011) 0.78
High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite? Hypertension (2012) 0.77
The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol. Int J Obes (Lond) (2014) 0.77
Renal glucose release during hypoglycemia is partly controlled by sympathetic nerves - a study in pigs with unilateral surgically denervated kidneys. Physiol Rep (2015) 0.77
Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Ther Adv Endocrinol Metab (2016) 0.77
Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms. J Physiol (2014) 0.76
Translational toxicology: a developmental focus for integrated research strategies. BMC Pharmacol Toxicol (2013) 0.76
Endocrine determinants of changes in insulin sensitivity and insulin secretion during a weight cycle in healthy men. PLoS One (2015) 0.76
Traditional Chinese Medicine for Metabolic Syndrome via TCM Pattern Differentiation: Tongue Diagnosis for Predictor. Evid Based Complement Alternat Med (2016) 0.76
Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study. Int J Hypertens (2013) 0.76
Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLoS One (2016) 0.76
Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review. Int J Prev Med (2014) 0.75
Non-interventional management of resistant hypertension. World J Cardiol (2014) 0.75
Fruit and Vegetable Intake in Relation to Lower Urinary Tract Symptoms and Erectile Dysfunction Among Southern Chinese Elderly Men: A 4-Year Prospective Study of Mr OS Hong Kong. Medicine (Baltimore) (2016) 0.75
Role of Autonomic Nervous System and Orexinergic System on Adipose Tissue. Front Physiol (2017) 0.75
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 0.75
Central Leptin and Tumor Necrosis Factor-α (TNFα) in Diurnal Control of Blood Pressure and Hypertension. J Biol Chem (2016) 0.75
Catheter-based renal denervation for treatment of resistant hypertension. JRSM Cardiovasc Dis (2013) 0.75
Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss. Front Physiol (2016) 0.75
Saturated high-fat diet-induced obesity increases adenylate cyclase of myocardial β-adrenergic system and does not compromise cardiac function. Physiol Rep (2016) 0.75
Adrenal medullary dysfunction as a feature of obesity. Int J Obes (Lond) (2017) 0.75
Subthreshold α₂-adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion. Exp Diabetes Res (2010) 0.75
Arcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways. J Clin Invest (2017) 0.75
Deletion of interleukin 1 receptor associated kinase 1 (IRAK1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle. J Biol Chem (2017) 0.75
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med (2006) 5.54
Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA (2010) 4.33
Renin-angiotensin system and cardiovascular risk. Lancet (2007) 3.47
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med (2009) 2.97
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry (2008) 2.43
Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology (2005) 2.42
Systematic review of medium-term weight loss after bariatric operations. Obes Surg (2006) 2.37
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Renal denervation in moderate to severe CKD. J Am Soc Nephrol (2012) 2.21
Sentinel lymph node biopsy now has a limited role in melanoma management. Aust Fam Physician (2014) 2.19
Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension (2012) 2.17
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens (2007) 2.09
Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care (2009) 2.04
Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care (2009) 2.00
QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol (2008) 1.85
Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2008) 1.80
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr (2008) 1.75
Weight loss and early and late complications--the international experience. Am J Surg (2002) 1.72
Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens (2011) 1.70
Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res (2008) 1.66
The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg (2002) 1.64
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis (2013) 1.60
Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens (2013) 1.54
Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension (2012) 1.52
General practice research--does gender affect the decision to participate? Aust Fam Physician (2012) 1.52
Sweet eating is not a predictor of outcome after Lap-Band placement. Can we finally bury the myth? Obes Surg (2002) 1.46
Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab (2005) 1.45
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis (2008) 1.44
Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity (Silver Spring) (2010) 1.40
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab (2005) 1.39
Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics. Nephrol Dial Transplant (2002) 1.39
High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens (2007) 1.37
Loss of control is central to psychological disturbance associated with binge eating disorder. Obesity (Silver Spring) (2008) 1.34
Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension (2007) 1.33
A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg (2005) 1.32
Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity (Silver Spring) (2008) 1.31
Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding. Obes Surg (2008) 1.31
Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep (2008) 1.29
Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab (2004) 1.28
Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr (2006) 1.26
Sympatho-renal axis in chronic disease. Clin Res Cardiol (2011) 1.26
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes (2012) 1.25
Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care (2012) 1.22
2011 Young Investigator Award winner: Increased fat mass is associated with high levels of low back pain intensity and disability. Spine (Phila Pa 1976) (2011) 1.16
Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol (2011) 1.15
The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep (2012) 1.13
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens (2009) 1.13
The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab (2006) 1.13
The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res (2010) 1.12
Baroreflex sensitivity: a reliable predictor of response to renal denervation? J Am Coll Cardiol (2014) 1.09
Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol (2010) 1.08
Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens (2008) 1.08
Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res (2007) 1.08
Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens (2012) 1.06
Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover. J Physiol (2011) 1.03
Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes (2009) 1.02
Lap-band: outcomes and results. J Laparoendosc Adv Surg Tech A (2003) 1.02
Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol (2011) 1.02
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol (2013) 1.01
Reduction in basal nitric oxide activity causes albuminuria. Diabetes (2011) 1.01
Laparoscopic adjustable gastric banding. Surg Obes Relat Dis (2006) 1.01
Patient motivation for bariatric surgery: characteristics and impact on outcomes. Obes Surg (2004) 1.00
Eating behavior as a prognostic factor for weight loss after gastric bypass. Obes Surg (2007) 1.00
Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men. Pharmacogenet Genomics (2011) 1.00
IDF's view of bariatric surgery in type 2 diabetes. Lancet (2011) 0.99
Bariatric surgery for diabetes: the International Diabetes Federation takes a position. J Diabetes (2011) 0.98
Laparoscopic adjustable gastric banding in the treatment of morbid obesity. Arch Surg (2003) 0.98
The extent of the problem of obesity. Am J Surg (2002) 0.97
Sympathetic activation in chronic kidney disease: out of the shadow. Hypertension (2011) 0.97
Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study. J Hypertens (2012) 0.95
The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab (2010) 0.95
The relationship between body composition and structural changes at the knee. Rheumatology (Oxford) (2010) 0.94
Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol (2009) 0.94
Association of weight gain with incident knee pain, stiffness, and functional difficulties: a longitudinal study. Arthritis Care Res (Hoboken) (2013) 0.94
Obesity management: update on orlistat. Vasc Health Risk Manag (2007) 0.94
Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle mass. Arthritis Care Res (Hoboken) (2012) 0.94
Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension (2011) 0.93
Symmetrical pouch dilatation after laparoscopic adjustable gastric banding: incidence and management. Obes Surg (2008) 0.92
Patient management after LAP-BAND placement. Am J Surg (2002) 0.92
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91